US EditionPublished • loading... • Updated
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Quest Diagnostics will outline its strategic priorities and discuss market trends at the J.P. Morgan Healthcare Conference, addressing investors and industry participants.
- Quest Diagnostics executives Jim Davis and Sam Samad will speak at the J.P. Morgan Healthcare Conference, presenting their strategy and performance.
- The company said it will outline its strategy and performance and cover market developments and trends at the conference.
- At the San Francisco conference, Quest Diagnostics will present during the 44th Annual J.P. Morgan Healthcare Conference in a presentation and Q&A session.
- Quest Diagnostics Incorporated is described as a leading national provider of diagnostic information services and trades on the NYSE under ticker DGX.
- Scheduled for Monday, January 12, 2026, at 4:30 p.m. Pacific Time, the presentation is part of the J.P. Morgan Healthcare Conference, announced from Secaucus, N.J.
Insights by Ground AI
23 Articles
23 Articles
Helena Independent Record+22 Reposted by 22 other sources
Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference
SECAUCUS, N.J., Dec. 19, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading national provider of diagnostic information services, announced that Jim Davis, Chairman, CEO and President, and Sam Samad, Executive Vice President and Chief Financial Officer, will speak…
·Helena, United States
Read Full ArticleCoverage Details
Total News Sources23
Leaning Left1Leaning Right0Center11Last UpdatedBias Distribution92% Center
Bias Distribution
- 92% of the sources are Center
92% Center
C 92%
Factuality
To view factuality data please Upgrade to Premium
